Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 1.787
-0.113 (-5.95%)
May 30, 2025, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 620.44 million as of May 30, 2025. Its market cap has decreased by -86.48% in one year.
Market Cap
620.44M
Enterprise Value
-462.64M
Revenue
87.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.79
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 620.44M, a decrease of -88.77%. That is a compound annual growth rate of -33.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 620.44M | -37.62% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.78B |
| Nordhealth AS | 2.97B |
| Photocure ASA | 1.32B |
| Vistin Pharma ASA | 1.15B |
| Omda AS | 1.10B |
| Gentian Diagnostics ASA | 900.67M |
| Hofseth BioCare ASA | 900.27M |
| ArcticZymes Technologies ASA | 806.93M |